Amrutanjan Health Care Limited

AMRUTANJAN

INE098F01031

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:50 2024-05-13 am EDT			5-day change	1st Jan Change
735.4 ^INR	-1.70%		-2.40%	+22.64%

Feb. 09	Amrutanjan Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
Feb. 09	Amrutanjan Health Care Limited Declares Second Interim Dividend for the Financial Year 2023-24	CI

Tranche Update on Amrutanjan Health Care Limited's Equity Buyback Plan announced on June 30, 2023.

August 02, 2023 at 05:57 am EDT

From July 1, 2023 to July 25, 2023, the company has repurchased 320,000 shares, representing 1.09% for INR 288 million. With this, the company has completed the repurchase of 320,000 shares, representing 1.09% for INR 288 million under the buyback announced on June 30, 2023.

Latest news about Amrutanjan Health Care Limited

Amrutanjan Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 09	CI
Amrutanjan Health Care Limited Declares Second Interim Dividend for the Financial Year 2023-24	Feb. 09	CI
Amrutanjan Health Care Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 10	CI
Amrutanjan Health Care Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 10	CI
Amrutanjan Health Care Limited Declares First Interim Dividend for the Financial Year 2023-2024	Nov. 10	CI
Amrutanjan Health Care Limited Declares Final Dividend for the Year Ended March 31, 2023	23-09-21	CI
Tranche Update on Amrutanjan Health Care Limited's Equity Buyback Plan announced on June 30, 2023.	23-08-02	CI
Amrutanjan Health Care Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-02	CI
Tranche Update on Amrutanjan Health Care Limited's Equity Buyback Plan announced on June 30, 2023.	23-08-02	CI
Amrutanjan Health Care Limited's Equity Buyback announced on June 30, 2023, has closed with 320,000 shares, representing 1.09% for INR 288 million.	23-07-24	CI
Amrutanjan Health Care Gets Board's Nod to Buy Back Up to INR288 Million Worth of Shares; Shares Surge 12%	23-06-30	MT
Amrutanjan Health Care Limited Announces Board Changes	23-06-30	CI
Amrutanjan Health Care Limited announces an Equity Buyback for 320,000 shares, representing 1.09% for INR 288 million.	23-06-30	CI
Amrutanjan Health Care Limited authorizes a Buyback Plan.	23-06-29	CI
Amrutanjan Health Care Limitedâ€™sÂ Board intends to launch an Equity Buyback onÂ June 30, 2023.	23-06-28	CI
Amrutanjan Health Care Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-31	CI
Amrutanjan Health Care Limited Recommends Final Dividend for the Financial Year 2022-2023	23-05-30	CI
Amrutanjan Health Care Limited Announces Demise of Pasumarthi Sathyanarayana Murthi, Non-Executive Non Independent Director	23-04-10	CI
India's Amrutanjan Health Care sinks on whistleblower allegations	23-02-15	RE
Amrutanjan Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-14	CI
Amrutanjan Health Care Limited Declares Interim Dividend for the Financial Year 2022-23	23-02-14	CI
INDIA STOCKS-Indian shares may open higher, tracking Asia, lower oil prices	22-11-06	RE
Amrutanjan Health Care Limited Declares First Interim Dividend for the Financial Year 2022-23	22-11-04	CI
Amrutanjan Health Care Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-04	CI
India's Amrutanjan Health Care Q2 profit slides as pandemic demand wanes	22-11-04	RE

Chart Amrutanjan Health Care Limited

Duration

Period

More charts

Company Profile

Amrutanjan Health Care Limited is an India-based company, which is engaged in the business of manufacturing, supplying and sale of products in pain management, congestion management, beverages, and hygiene. Its segments include OTC Products, Beverages, and Others. The OTC Products segment is engaged in manufacturing products for pain management, congestion management and hygiene. The Beverages segment is engaged in manufacturing fruit juices and oral hydration drinks. The Others segment includes the pain management center. The Companyâs pain management products include Pain Balm Extra Power, Strong Pain Balm, New Maha Strong Pain Balm, Roll on and Advanced Back Pain + Roll-On, among others. Its congestion management products include Relief Cold Rub, Relief Nasal Inhaler, Relief Cough Syrup and Relief Swas Mint. Its women's hygiene products include Comfy Snug Fit, Comfy Snug Fit XL and Comfy Snug Fit ULTRA XL. The Companyâs beverages include Fruitnik and Fruitnik Electro+.

Sector

Pharmaceuticals

Calendar

2024-05-22 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
AMRUTANJAN HEALTH CARE LIMITED	+22.64%	259M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.09%	43.27B
OTSUKA HOLDINGS CO., LTD.	+25.28%	22.92B
SANDOZ GROUP AG	+19.22%	15.43B
CIPLA LIMITED	+13.51%	12.95B
ZYDUS LIFESCIENCES LIMITED	+44.01%	11.83B
ONO PHARMACEUTICAL CO., LTD.	-7.79%	6.91B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+13.26%	5.55B

Generic Pharmaceuticals

Amrutanjan Health Care Limited

Equities

AMRUTANJAN

INE098F01031

Pharmaceuticals

Tranche Update on Amrutanjan Health Care Limited's Equity Buyback Plan announced on June 30, 2023.

Latest news about Amrutanjan Health Care Limited

Chart Amrutanjan Health Care Limited

Company Profile

Income Statement Evolution

Sector Generic Pharmaceuticals